Academic Journals Database
Disseminating quality controlled scientific knowledge

The safety of ustekinumab in the treatment of psoriasis Bezpieczeństwo stosowania ustekinumabu w leczeniu łuszczycy

Author(s): Rafał Białynicki-Birula | Eugeniusz Baran

Journal: Clinical Dermatology
ISSN 1730-7201

Volume: 13;
Issue: 2;
Start page: 95;
Date: 2011;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: ustekinumab | łuszczyca | wyniki leczenia | toksyczność leków | działania niepożądane | ustekinumab | psoriasis | treatment outcome

Psoriasis is a chronic disease, thus requiring chronic therapy. The Adverse Events (AE) which can be caused by ustekinumab in the treatment of psoriasis were discussed in detail. The drug is safe as long as all the criteria are fulfilled before the introducing of the treatment. Data were based on the basis of information collected from several Randomized Controlled Trial (RCT) that enrolled 3219 patients. In conclusion it should be noted that ustekinumab meets the criteria for ""magic bullet"", which was a dream of Paul Ehrlich (1854-1915). What is interesting - ustekinumab was introduced exactly 100 years after salvarsan (1909-2009).
Why do you need a reservation system?      Affiliate Program